
Guardant Health, Inc.
NASDAQ:GH
42.1 (USD) • At close June 2, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Guardant Health, Inc. |
Symbool | GH |
Munteenheid | USD |
Prijs | 42.1 |
Beurswaarde | 5,215,684,800 |
Dividendpercentage | 0% |
52-weken bereik | 20.14 - 52.92 |
Industrie | Diagnostics & Research |
Sector | Healthcare |
CEO | Dr. Helmy Eltoukhy Ph.D. |
Website | https://guardanthealth.com |
An error occurred while fetching data.
Over Guardant Health, Inc.
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)